Frequently
Asked
Questions

Psilocybin is a naturally occurring compound found in more than 200 species of fungi. When consumed, the body converts it into psilocin, the active form that interacts with the brain's serotonin system, producing shifts in perception, emotion, and sense of self. It is not manufactured or synthesized. It grows from the earth, as it always has.

What makes psilocybin worth understanding is not just the compound itself, but the organism it comes from. Fungi are among the oldest living systems on the planet. The mycelial network, sometimes called nature's internet, is a vast underground web through which fungi share nutrients, information, and support across entire ecosystems. A single teaspoon of healthy forest soil can contain miles of mycelial thread.

Researchers at Johns Hopkins University, NYU Langone, and Imperial College London have spent the last two decades building a rigorous understanding of what psilocybin actually does in the brain.

When converted to psilocin, it binds primarily to serotonin receptors — particularly the 5-HT2A receptor — in ways that temporarily disrupt what researchers call the Default Mode Network, or DMN. The DMN is the neural system associated with our habitual sense of self. The inner narrator. The ruminative loops. The deeply grooved patterns of thought that can keep us stuck long after the circumstances that created them have changed.

When that network quiets, the brain shifts into a more open, interconnected state. Regions that don't typically communicate begin to do so. Researchers describe this as increased neural flexibility — a kind of organized openness that appears to allow new perspectives, emotional processing, and lasting behavioral change.

In 2006, Johns Hopkins researchers found that a single guided psilocybin experience produced substantial and sustained improvements in wellbeing — effects that held more than a year later in follow-up assessments.¹ In 2018, the FDA designated psilocybin a Breakthrough Therapy for treatment-resistant depression, a designation reserved for treatments showing early evidence of meaningful improvement over existing options.²

What the science keeps pointing to is this: in a supported, intentional setting, psilocybin appears to create conditions for the brain to learn something new about itself. We find that remarkable. And we take it seriously.

Studies have found significant reductions in symptoms of treatment-resistant depression and major depressive disorder following guided psilocybin sessions — with effects lasting months beyond the experience itself.³ Research with cancer patients facing end-of-life anxiety has shown meaningful reductions in fear and emotional suffering, alongside increased acceptance and peace.⁴ Studies at both Johns Hopkins and NYU have found promising results for addiction — particularly smoking cessation and alcohol use disorder — with some participants maintaining abstinence well beyond the treatment period.⁵ And across multiple studies with healthy participants, researchers have documented lasting increases in openness, life satisfaction, and a felt sense of connection — what many participants described as among the most meaningful experiences of their lives.¹

Beyond the clinical findings, many people who work with psilocybin in supported settings describe something harder to measure. A softening of the inner critic. A return to their own values. A renewed sense of belonging — to themselves, to the people around them, to something larger. We hear this often. We don't think it is incidental.

Although psilocybin services are widely regarded as safe for many individuals, there are important considerations and potential risks to keep in mind. For instance, these services may not be appropriate for people with a personal or family history of certain mental health conditions, including schizophrenia or bipolar disorder. If you have concerns about whether this experience is right for you, we recommend consulting with your primary healthcare provider.

Oregon law requires that all clients complete a health screening with a licensed facilitator before any administration session. We take that seriously — not as a formality, but as a genuine conversation about whether this is the right time for you.

Psilocybin is generally not recommended for people who have a personal or family history of schizophrenia, schizoaffective disorder, bipolar disorder, or other psychotic disorders. It is also not recommended for those currently experiencing active suicidal ideation, those who have taken lithium within the past 30 days, those in active or severe withdrawal from alcohol or other substances, or those with certain cardiovascular conditions including uncontrolled hypertension or a history of cardiac arrest.

This list is not exhaustive. Your facilitator will review your health history with care and with honesty. If psilocybin is not the right fit right now, we will say so — and we will do our best to help you find support that is.

There is no shame in waiting. The door stays open.

The cost of a personalized psilocybin journey, including preparation, administration, and follow-up integration, ranges from approximately $2,000 to $3,500. Cost variability reflects differences in facilitator rates.

For those newer to psilocybin or looking for a lighter entry point, we also offer low-dose journeys starting at $100–$200, plus the cost of psilocybin.

Group weekend retreats are available starting at $2,900–$4,000 per person.

We are committed to accessibility and offer a limited number of reduced-cost options. We are happy to discuss what might work for you during your consultation call.